Taiwan Advance Bio-Pharmaceutical Inc.
4186.TWO
Price:
$11.65
Market Cap:
$1.05B
Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. The company provides food safety diagnostic testing kits; ELISA, rapid, and chemical test kits customization, and food safety lab establishment consultation services; and manufactures monoclonal and polyclonal antibody products. It also offers abused drugs rapid tests; provides cell banking services for newborn and adult stem cells storage; and operates drug testing center for urine drug test, hair drug test, and identification of drug abuse. The company was founded in 1989 and is based in New T...[Read more]
Industry
Biotechnology
IPO Date
2012-11-27
Stock Exchange
TWO
Ticker
4186.TWO
PE Ratio
[44.81]
ROE
[9.19%]
Current Ratio
[0.90]
Dividend Yield
[0%]
Enterprise Value
[1.20B]
Dividend History
The ROE as of December 2025 (TTM) for Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) is 9.19%
According to Taiwan Advance Bio-Pharmaceutical Inc.’s latest financial reports and current stock price. The company's current ROE is 9.19%. This represents a change of 101.95% compared to the average of 4.55% of the last 4 quarters.
Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) Historical ROE (quarterly & annually)
How has 4186.TWO ROE performed in the past?
The mean historical ROE of Taiwan Advance Bio-Pharmaceutical Inc. over the last ten years is -26.16%. The current 9.19% ROE has changed -135.14% with respect to the historical average. Over the past ten years (40 quarters), 4186.TWO's ROE was at its highest in in the December 2023 quarter at 11.04%. The ROE was at its lowest in in the December 2019 quarter at -44.74%.
Average
-26.16%
Median
-14.32%
Minimum
-89.48%
Maximum
8.92%
Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of Taiwan Advance Bio-Pharmaceutical Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 103.93%
Maximum Annual ROE = 8.92%
Minimum Annual Increase = -452.42%
Minimum Annual ROE = -89.48%
| Year | ROE | Change |
|---|---|---|
| 2024 | 8.92% | -295.34% |
| 2023 | -4.57% | -452.42% |
| 2022 | 1.30% | -102.64% |
| 2021 | -49.09% | 103.93% |
| 2020 | -24.07% | -73.10% |
Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) Average ROE
How has 4186.TWO ROE performed in the past?
The current ROE of Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.88%
5-year avg
-13.50%
10-year avg
-26.16%
Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) ROE vs. Peers
How is 4186.TWO’s ROE compared to its peers?
Taiwan Advance Bio-Pharmaceutical Inc.’s ROE is greater than LabTurbo Biotech Corporation (-12.54%), greater than Bio Preventive Medicine Corp. (-24.73%), greater than Lukas Biomedical Inc. (-31.59%), greater than NeoCore Technology Co., Ltd. (-5.81%), less than Level Biotechnology Inc. (12.44%), greater than MegaPro Biomedical Co., Ltd (-91.17%), less than TCI GENE Inc. (3.64%), less than BiOptic Inc. (4.93%), greater than Neith Corporation (-0.50%), greater than LAUNXP Biomedical Co., Ltd (-56.54%),
| Company | ROE | Market cap |
|---|---|---|
| -12.54% | $1.12B | |
| -24.73% | $1.14B | |
| -31.59% | $1.33B | |
| -5.81% | $1.52B | |
| 12.44% | $1.08B | |
| -91.17% | $1.02B | |
| 3.64% | $984.26M | |
| 4.93% | $1.36B | |
| -0.50% | $1.22B | |
| -56.54% | $1.12B |
Build a custom stock screener for Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Taiwan Advance Bio-Pharmaceutical Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Taiwan Advance Bio-Pharmaceutical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Taiwan Advance Bio-Pharmaceutical Inc.'s ROE?
How is the ROE calculated for Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO)?
What is the highest ROE for Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO)?
What is the 3-year average ROE for Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO)?
What is the 5-year average ROE for Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO)?
How does the current ROE for Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) compare to its historical average?